SSCRIMED
Healthcare buyerUnderstand SCRIMED quicklyDemo, pilot, or pricing ownerConvert demo interest into a priced pilot pathInvestor, strategic partner, or faith-based clinic sponsorUnderstand SCRIMED's investable and sellable value safely
Pilot Programs

sellable-now · 30 days

30-Day Workflow Intelligence Sprint

Convert one to three fragmented workflows into a prioritized operating map, measurable value hypothesis, and governed pilot decision.

Duration30 days
EngagementRecommended fixed-fee range: $25k-$75k; mission-clinic access path $12.5k-$25k for one no-PHI workflow with capped artifacts
Included demos3
Decision metrics4
Commercial path0 demos

Target buyer

Healthcare operators selecting the first high-value workflow for governed AI transformation

Recommended fixed-fee range: $25k-$75k; mission-clinic access path $12.5k-$25k for one no-PHI workflow with capped artifacts

Request this pilot
01Current-state workflow and friction map
02Automation candidate scorecard
03Agent, reviewer, and interoperability responsibility map
04Baseline measurement plan
05Executive pilot recommendation

Included product proof

Inspectable demos ground the pilot in real product surfaces.

Decision metric 01

Priority workflow approved

Measured against a buyer-approved operational baseline and governance boundary.

Decision metric 02

Baseline and target metrics defined

Measured against a buyer-approved operational baseline and governance boundary.

Decision metric 03

Governance gaps assigned owners

Measured against a buyer-approved operational baseline and governance boundary.

Decision metric 04

Pilot scope and decision criteria approved

Measured against a buyer-approved operational baseline and governance boundary.

Activation requirements

The pilot starts only when buyer inputs and governance gates are explicit.

Buyer inputs

Required context

Business, workflow, and operating information needed to produce decision-grade evidence.

  • Executive or operational sponsor
  • One to three workflow descriptions without PHI
  • Current friction and handoff context
  • Governance and interoperability requirements
Governance gates

Required controls

Conditions that keep the engagement auditable, human-reviewed, and healthcare-safe.

  • No PHI or patient-level records
  • Human-review operating model defined
  • Synthetic evidence scope approved
  • Production requirements listed separately
Production exclusions

Not included

Capabilities that remain denied or require a separate protected-production approval path.

  • No live workflow integration
  • No autonomous action
  • No production data processing
  • No clinical outcome claim
ProposalDownload pilot proposal

Share the proposed scope, commercial model, metrics, inputs, gates, and exclusions.

StartRequest this pilot

Open the governed enterprise intake with the closest matching service offer selected.

ProofInspect all demos

Review the product evidence that can be packaged into the engagement.

CommercialReview pricing strategy

Inspect expansion paths from evaluation into protected pilot and enterprise license.

AcceleratorReview market alignment

Inspect benchmark context, price bands, and demo-to-pilot routing.